Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.42 USD | 0.00% | +1.95% | -2.89% |
Sales 2024 * | 206M 16.45B | Sales 2025 * | 243M 19.47B | Capitalization | 856M 68.53B |
---|---|---|---|---|---|
Net income 2024 * | 19M 1.52B | Net income 2025 * | 30M 2.4B | EV / Sales 2024 * | 3.89 x |
Net cash position 2024 * | 56.01M 4.48B | Net cash position 2025 * | 93.09M 7.45B | EV / Sales 2025 * | 3.14 x |
P/E ratio 2024 * |
76.6
x | P/E ratio 2025 * |
45.3
x | Employees | 1,102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.86% |
Latest transcript on Enfusion, Inc.
1 week | +1.95% | ||
Current month | +1.84% | ||
1 month | +3.52% | ||
3 months | +11.74% | ||
6 months | +10.43% | ||
Current year | -2.89% |
Managers | Title | Age | Since |
---|---|---|---|
Oleg Movchan
FOU | Founder | 50 | 31/12/05 |
Bradley Herring
DFI | Director of Finance/CFO | 54 | 18/12/22 |
Dan Groman
CTO | Chief Tech/Sci/R&D Officer | 35 | 31/12/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen DeRose
BRD | Director/Board Member | 63 | 06/12/21 |
Brad Bernstein
BRD | Director/Board Member | 57 | 31/12/20 |
Director/Board Member | 63 | 31/05/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 9.42 | 0.00% | 219,291 |
25/04/24 | 9.42 | +1.29% | 327,594 |
24/04/24 | 9.3 | -0.53% | 256,905 |
23/04/24 | 9.35 | +1.30% | 552,040 |
22/04/24 | 9.23 | -0.11% | 239,902 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.89% | 847M | |
+8.05% | 3,020B | |
+5.58% | 82.93B | |
+3.69% | 76.85B | |
-14.62% | 53.04B | |
+31.16% | 50.15B | |
-24.56% | 46.55B | |
+17.75% | 41.41B | |
+55.21% | 35.63B | |
-10.24% | 24.64B |
- Stock Market
- Equities
- ENFN Stock